09540

The key to knowledge is in your (nitrile-gloved) hands

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

October 9, 2017 Cover

Volume 95, Issue 40

Emboldened by real-world success and powered by CRISPR, a new wave of biotech firms is revisiting the concept of synthetic lethality in cancer

Cover image:

Credit:

Full Article

Volume 95 | Issue 40

« Prev

Emboldened by real-world success and powered by CRISPR, a new wave of biotech firms is revisiting the concept of synthetic lethality in cancer

Hardy parasites have appeared in livestock around the world

But the small-molecule stalwart may surprise with its next investment

Materials

As computer chips shrink, cleaning needs grow

Suppliers of electronic cleaning chemicals seek to remove even trace contaminants
Business

Perspectives: A new world for pharma contractors

Trade association chief describes his move from the trenches of journalism to the front line on regulatory and legislative issues
Sponsored Content
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime